Latest news
VERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:46 GMTVERAXA Biotech (NASDAQ: VRXA) Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform - USA TodayUSA Today · Tue, 04 Aug 2026 04:28:55 GMTVeraxa Biotech (VRXA) grows patent estate for BiTAC cancer platforms - Stock TitanStock Titan · Fri, 31 Jul 2026 20:05:41 GMTVERAXA Biotech (NASDAQ: VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms - USA TodayUSA Today · Thu, 30 Jul 2026 03:17:11 GMTVERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates - The Manila TimesThe Manila Times · Wed, 29 Jul 2026 11:20:51 GMTVERAXA filings expected to protect core tech through at least 2047 if granted - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTVERAXA Biotech (NASDAQ: VRXA) Shareholders Approve Corporate Governance, Financing Measures - TradingViewTradingView · Tue, 28 Jul 2026 16:36:58 GMT